Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in Australia
Sign Up to like & getrecommendations! Published in 2025 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-025-01489-w
Abstract: Despite international evidence demonstrating pre-emptive pharmacogenetics (PGx) screening is cost effective or cost saving in preventing serious or fatal toxicities, it is not routinely adopted in Australia. This study evaluated the cost effectiveness of PGx… read more here.
Keywords: pgx screening; treatment; pre emptive; cost ... See more keywords